| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.31 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |